Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Coral LaboratoriesBOM:524506 72 Dividend Yield % is 0.26% as of Aug. 11, 2026, which is 51% below its 10-year median of 0.53. GuruFocus rates BOM:524506 with a GF Score™ of 72/100 and a GF Value™ of ₹483.47 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 512 Drug Manufacturers companies, Coral Laboratories ranks worse than 90.43% on this metric.
As of today (2026-08-11), the Trailing Annual Dividend Yield of Coral Laboratories is 0.26%.
Warning Sign:
Coral Laboratories Ltd stock Dividend Yield % is close to 1-year low.
The historical rank and industry rank for Coral Laboratories's Dividend Yield % or its related term are showing as below:
BOM:524506'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.23 Med: 0.53 Max: 2.02
Current: 0.26
During the past 13 years, the highest Dividend Yield of Coral Laboratories was 2.02%. The lowest was 0.23%. And the median was 0.53%.
BOM:524506's Dividend Yield % is ranked worse than 90.43% of 512
companies
in the Drug Manufacturers industry
Industry Median: 1.975
vs BOM:524506: 0.26
During the past 12 months, Coral Laboratories's average Dividends Per Share Growth Rate was -25.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Coral Laboratories was 35.70% per year. The lowest was -12.60% per year. And the median was 8.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Coral Laboratories Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Coral Laboratories's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Coral Laboratories's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coral Laboratories Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Coral Laboratories's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Coral Laboratories's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Coral Laboratories Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 1.500000
2025-09-19
2025-09-20
2025-10-13
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Coral Laboratories's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coral Laboratories (BOM:524506) has a Dividend Yield % of 0.26% as of Aug. 11, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Coral Laboratories and its competitors. This is 51% below median its historical median of 0.53. Over the past decade, Coral Laboratories' Dividend Yield % has ranged from 0.23 to 2.02. According to the industry distribution chart, Coral Laboratories ranks #463 out of 512 companies in the Drug Manufacturers industry, placing it in the top 90.4%.
Is Coral Laboratories' Dividend Yield % too high?
Coral Laboratories' current Dividend Yield % of 0.26% is 51% below median its 10-year median of 0.53. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 2.02. The Drug Manufacturers industry median Dividend Yield % is 1.98. Coral Laboratories' value of 0.26% is 86.8% below this industry median. Based on the distribution chart, Coral Laboratories ranks #463 out of 512 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Coral Laboratories has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Coral Laboratories' Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Coral Laboratories ranks #463 out of 512 companies for Dividend Yield %. This places Coral Laboratories in the lower half of its industry. The industry median Dividend Yield % is 1.98. Coral Laboratories' value of 0.26% is 86.8% below this benchmark. Historically, Coral Laboratories' own Dividend Yield % has ranged from 0.23 to 2.02 over the past decade. While the company's 10-year median is 0.53 vs. the industry median of 1.98, Coral Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.98, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coral Laboratories's current Dividend Yield % of 0.26% is 86.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Coral Laboratories and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coral Laboratories's current Dividend Yield % is 0.26%, which is 51% below median its own 10-year median of 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coral Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Coral Laboratories (BOM:524506) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹483.47, compared to a current price of ₹577.90 — trading 19.5% above its estimated fair value. The current Dividend Yield % is 0.26%, which is 51% below median its 10-year median of 0.53 and 86.8% below the Drug Manufacturers industry median of 1.98. Coral Laboratories' overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Coral Laboratories (BOM:524506), the current Dividend Yield % is 0.26% as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coral Laboratories (BOM:524506) Overvalued in 2026?
Based on GuruFocus' analysis, Coral Laboratories stock appears to be overvalued.
The current stock price of ₹577.90 is trading 19.5% above its estimated GF Value™ of ₹483.47.
GuruFocus considers Coral Laboratories to be Modestly Overvalued.
Key valuation signals for BOM:524506:
Dividend Yield %: 0.26% (51% below median its 10-year median of 0.53)
GF Value™: ₹483.47 vs. price of ₹577.90 (19.5% above fair value)
Industry Position: 86.8% below the Drug Manufacturers median (#463 of 512)
No single metric tells the full story. See the BOM:524506 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coral Laboratories Ltd is engaged in the pharmaceutical business. The company is involved in the formulation of medicines. The company's dosage form includes tablets, capsules, liquid orals, b-lactam, dry syrup, meter dose inhalers, injectables, drops, sprays, special kits, and others. Its geographical segments include Ethiopia, India, and the Rest of the world.
72GF Score
Get the complete analysis for BOM:524506
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524506 has been successfully added to your 
